Headquartered in Pittsburgh, the Community Liver Alliance has grown to have a national presence while still holding true to a mission to invest in local communities and give voice to patients and providers. The CLA is dedicated to supporting the community through liver disease awareness, prevention, education, advocacy and research.
Supported by a network of patients, caregivers, health care professionals and community leaders, CLA develops and runs educational workshops, coordinates support groups, facilities linkage to medical care and provides education to health care professionals, patients and caregivers.
CLA collaborates with community leaders, interest groups and policy makers on issues related to liver disease health.
CLA's goal is continued growth aligned with mission and strategic plans. With the support of key funding partners, CLA continues to build capacity to address autoimmune liver diseases, the elimination of viral hepatitis and the other rising liver-related epidemics like Fatty Liver/NASH and Hepatocellular Carcinoma.
CLA gives back to local communities through our Liver Hero funds that support Patients, Research and Pediatric Initiatives.
CLA is involved in advancing policy related to healthcare issues at both the state and federal level, regularly providing expertise and amplifying patient and provider voices to help advocates communicate to legislators about important health care issues such as non-medical switching, out of pocket costs for prescription drugs, co-pay accumulator issues, as well as other barriers to health care access, and seek state-level and federal policy remedies.
CLA is YOUR community partner and is dedicated to working with you providing support to the liver community. CLA lives the mission and is committed to providing excellent outcomes for all endeavors, achieved through solid relationships with strategic partners, volunteer leaders and by selecting highly experienced and dedicated staff members to meet the needs of the liver communities across the nation.
CLA is dedicated to supporting harm reduction as a practice and a theory. Meeting people where they are, using proven practical public health strategies to help remove barriers, increasing educational opportunities, expanding health access and treating people with love, respect and dignity has and will continue to help eliminate health disparities including all forms of liver disease.